Search over 3,000 reports

    Fusilev- Drug Insight, 2017

    Fusilev- Drug Insight, 2017
    Date: Jan, 2018
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0355
    "Fusilev - Drug Insight, 2018" report by DelveInsight provides comprehensive information of the drug, Fusilev. It includes Fusilev`s overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Fusilev`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted sales of Fusilev till 2020. The report also throws light on Fusilev`s market competition and emerging therapies in the same space as Fusilev. A SWOT analysis of Fusilev is also featured.
    * Depending on information availability

    Methodology
    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    • A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
    • Patent information around Fusilev in United States (US) and Europe (EU) has been highlighted
    • API manufacturers for Fusilev in United States, Europe, China and India
    • The report contains historical and forecasted sales for Fusilev till 2020
    • Comprehensive coverage of the emerging therapies (Phase III) in the space where Fusilev operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
    • The report also features the SWOT analysis of Fusilev

    Reasons to Buy
    • Establish a comprehensive understanding of the drug, Fusilev
    • Access to Fusilev`s API manufacturers details to devise API procurement strategy for generic development
    • Plan developmental timelines around Fusilev`s patents for the major markets- US and EU
    • Understand Fusilev`s current and future growth through its historical and forecasted sales
    • Identify and understand the current in-market competitors for Fusilev
    • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    • Identify and plan ahead for prospective emerging players and their products operating in the same space as Fusilev
    • Identify opportunities in the same area as Fusilev with DelveInsight`s SWOT analysis
    1. Report Introduction
    2. Fusilev - Overview
    • Product Description
    • Route of Synthesis
    • Mechanism of Action
    • Pharmacology
    • Pharmacodynamics
    • Pharmacokinetics
    • Adverse Reactions
    • Clinical Trials
    • Regulatory Milestones
    • Product Development Activities
    3. Global API Manufacturers
    • United States
    • Europe
    • China
    • India
    4. Product Details
    • United States
    • Europe
    5. Fusilev Global Sales Assessment
    • Historical Global Sales
    • Forecasted Global Sales
    6. Patent Details
    7. Market Competition
    8. Emerging Therapies
    8.1. Drug name: Company name
    • Product Description
    • Research & Development
    • Product Development Activities
    Other product profiles in the detailed report…..
    9. SWOT Analysis
    Appendix
    Methodology
    Consulting Services
    About DelveInsight
    Contact Us
    Disclaimer
    Note: Certain sections of the table of contents would vary according to the availability of information
    Table 1: Fusilev, Description
    Table 2: API Manufacturers Region wise
    Table 3: API Manufacturers for United States
    Table 4: API Manufacturers for Europe
    Table 5: API Manufacturers for China
    Table 6: API Manufacturers for India
    Table 7: Fusilev Product Details, United States
    Table 8: Fusilev Product Details, Europe
    Table 9: Fusilev, Historical Global Sales till 2017 (in million USD)
    Table 10: Fusilev, Forecasted Global Sales from 2018-2020 (in million USD)
    Table 11: Patent Details: Fusilev
    Table 12: Fusilev Major Competitors
    Table 13: Emerging Therapies
    Figure 1: Fusilev
    Figure 2: Fusilev, Historical Global Sales till 2017 (in million USD)
    Figure 3: Fusilev, Forecasted Global Sales from 2018-2020 (in million USD)
    Figure 4: Patent Details: Fusilev
    Figure 5: API Manufacturers Region wise
    Fusilev

    Fusilev Marketed Drugs Overview

    Fusilev Market Assessment

    Fusilev API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers

    Fusilev US DMF

    Fusilev US Drug Master Files

    Fusilev Active Substance Master File/ EUDMF

    Fusilev Generic players

    Fusilev Patent Expiration

    Fusilev Patent Exclusivity

    Fusilev API Manufacturers

    Fusilev Global Forecasted Sales Figure

    Fusilev API Route of Synthesis

    Fusilev Market sales

    Fusilev SWOT Analysis

    Fusilev Pipeline

    • Single User License
      (20% Off)
      $1,000.00
    • Site License
      (30% Off)
      $2,000.00
    • Global License
      (40% Off)
      $3,000.00

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap